• 분석과학
• /
• 제25권5호
• /
• pp.307-312
• /
• 2012

4급 암모늄 계열의 대표적인 살균제인 didecyldimethylammonium chloride(DDAC)는 흡입 경로에 의해 폐 섬유화 등의 폐질환을 일으킬 가능성이 높은 물질로, 흡입독성시험을 위하여 전신 흡입노출 챔버 내에 에어로졸 형태로 분무된 DDAC의 포집 및 분석방법을 검토하였다. DDAC의 포집 회수율은 아세토니트릴을 사용하여 탈착한 XAD 흡착제의 회수율이 87.8%로 실리카겔의 경우보다 우수한 것으로 나타났다. 이온크로마토그라프-전기전도도 검출기로 분석한 DDAC의 검출한계(MDL, method detection limit)는 0.18 ${\mu}g/mL$이었으며, 정량한계(LOQ, limit of quantitation)는 0.54 ${\mu}g/mL$였다. 공기 포집량 240 L를 기준으로 챔버 내 공기 중 농도로 환산하면 MDL이 2.97 ${\mu}g/m^3$, LOQ가 8.92 ${\mu}g/m^3$로, 챔버 내 발생 농도인 70~900 ${\mu}g/m^3$ 농도 수준의 모니터링에 적절하였다. 분석의 재현성은 0~20 ${\mu}g/mL$ 농도범위에서 상대오차 7.8% 내외였으며 시료 분석에 소요되는 시간은 5분 이내였다. 따라서 XAD를 사용한 DDAC의 포집 및 이온크로마토그라피를 이용한 분석방법은 실험동물을 사용한 전신 흡입노출 챔버 내 DDAC 농도의 신속하고 편리한 모니터링에 적절한 것으로 나타났다.

• Toxicological Research
• /
• 제33권1호
• /
• pp.7-14
• /
• 2017

Didecyldimethylammonium chloride (DDAC) is used in many types of biocidal products including tableware, carpets, humidifiers, and swimming pools, etc. In spite of increased chances of DDAC exposure through inhalation, studies on the inhalation toxicity of DDAC are not common even though the toxicity of DDAC might be significantly higher if it were to be administered through routes other than the respiratory system. DDAC aerosols were exposed to Sprague-Dawley rats in whole body exposure chambers for a duration of 13 weeks. The Mass Median Aerodynamic Diameters of the DDAC aerosol were $0.63{\mu}m$, $0.81{\mu}m$, and $1.65{\mu}m$, and the geometric standard deviations were 1.62, 1.65, and 1.65 in the low ($0.11{\pm}0.06mg/m^3$), the middle ($0.36{\pm}0.20mg/m^3$) and the high ($1.41{\pm}0.71mg/m^3$) exposure groups, respectively. Body weight was confirmed to be clearly influenced by exposure to DDAC and mean body weight was approximately 35% lower in the high ($1.41{\pm}0.71mg/m^3$) male group and 15% lower in the high ($1.41{\pm}0.71mg/m^3$) female group compared to that of the control group. In the bronchoalveolar lavage fluid assay, the levels of albumin and lactate dehydrogenase had no effect on DDAC exposure. The lung weight increased for the middle ($0.36{\pm}0.20mg/m^3$) and the high ($1.41{\pm}0.71mg/m^3$) concentrations of the DDAC exposure group, and inflammatory cell infiltration and interstitial pneumonia were partially observed in the lungs of the middle ($0.36{\pm}0.20mg/m^3$) and the high ($1.41{\pm}0.71mg/m^3$) exposure groups. However, severe histopathological symptoms, including proteinosis and/or fibrosis, were not found. Based on the results of the changes in the body weight and lung weight, it is considered that the NOAEL (no-observed adverse effect) level for the 13-week exposure duration is $0.11mg/m^3$.